Skip to Content

Asclera Approval History

FDA Approved: Yes (First approved March 30, 2010)
Brand name: Asclera
Generic name: polidocanol
Dosage form: Injection
Company: Chemische Fabrik Kreussler & Co.
Treatment for: Varicose Veins

Asclera (polidocanol) is a sclerosing agent used for the treatment of varicose veins.

Development History and FDA Approval Process for Asclera

DateArticle
Mar 31, 2010Approval FDA Approves Asclera to Treat Small Varicose Veins

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide